NOVAST LABORATORIES, INC. – Trademark Portfolio
Entity Type: 03
NOVAST LABORATORIES, INC. holds 60 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 59 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 20 trademarks are registered and 9 are pending. Notable registered marks include WERA, LARIN, LINYAH, DASETTA, and ELINEST. The owner is based in Irving, TX.
1212 Corporate Drive, Suite #123
Irving, TX 75038
Showing of trademarks Trademarks
Trademark Classifications
NOVAST LABORATORIES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does NOVAST LABORATORIES, INC. have?
NOVAST LABORATORIES, INC. has 60 U.S. trademarks filed with the USPTO. Of these, 20 registered, 9 pending, 31 abandoned.
What trademark classes does NOVAST LABORATORIES, INC. file in?
NOVAST LABORATORIES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NOVAST LABORATORIES, INC.'s most well-known trademarks?
NOVAST LABORATORIES, INC.'s registered trademark portfolio includes well-known marks such as WERA, LARIN, LINYAH, DASETTA, and ELINEST. These are among 20 currently registered trademarks in the portfolio.
What is NOVAST LABORATORIES, INC.'s trademark registration success rate?
NOVAST LABORATORIES, INC. has a 39% trademark registration rate, with 20 out of 51 resolved applications resulting in successful registration. Currently, 9 applications are pending review.